Amphastar Pharmaceuticals Management
Management criteria checks 3/4
Amphastar Pharmaceuticals' CEO is Jack Zhang, appointed in Jan 1996, has a tenure of 28.25 years. total yearly compensation is $7.72M, comprised of 11.6% salary and 88.4% bonuses, including company stock and options. directly owns 4.58% of the company’s shares, worth $91.55M. The average tenure of the management team and the board of directors is 10.4 years and 4.8 years respectively.
Key information
Jack Zhang
Chief executive officer
US$7.7m
Total compensation
| CEO salary percentage | 11.6% |
| CEO tenure | 28.3yrs |
| CEO ownership | 4.6% |
| Management average tenure | 10.4yrs |
| Board average tenure | 4.8yrs |
Recent management updates
Recent updates
Amphastar Pharmaceuticals (NASDAQ:AMPH) Has A Pretty Healthy Balance Sheet
Mar 27
Why Amphastar Pharmaceuticals Is A Strong Buy: Growth, Valuation, And Strategic Acquisitions
Mar 04Here's Why We Think Amphastar Pharmaceuticals (NASDAQ:AMPH) Might Deserve Your Attention Today
Jan 04Why Investors Shouldn't Be Surprised By Amphastar Pharmaceuticals, Inc.'s (NASDAQ:AMPH) P/E
Dec 20Amphastar Pharmaceuticals (NASDAQ:AMPH) Has A Rock Solid Balance Sheet
Dec 03Amphastar Pharmaceuticals (NASDAQ:AMPH) Ticks All The Boxes When It Comes To Earnings Growth
Sep 18An Intrinsic Calculation For Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Suggests It's 35% Undervalued
Sep 03These 4 Measures Indicate That Amphastar Pharmaceuticals (NASDAQ:AMPH) Is Using Debt Safely
Aug 17Here's Why We Think Amphastar Pharmaceuticals (NASDAQ:AMPH) Is Well Worth Watching
Jun 02We Think Amphastar Pharmaceuticals (NASDAQ:AMPH) Can Manage Its Debt With Ease
May 11Amphastar Pharmaceuticals, Inc.'s (NASDAQ:AMPH) Intrinsic Value Is Potentially 51% Above Its Share Price
Mar 02Is Now The Time To Put Amphastar Pharmaceuticals (NASDAQ:AMPH) On Your Watchlist?
Feb 07Does Amphastar Pharmaceuticals (NASDAQ:AMPH) Have A Healthy Balance Sheet?
Jan 24Here's Why Amphastar Pharmaceuticals (NASDAQ:AMPH) Has Caught The Eye Of Investors
Nov 02Amphastar: A Pharmaceutical Growth Stock
Oct 06Amphastar wins FDA approval for Epinephrine pre-filled syringes
Aug 16Amphastar Pharmaceuticals: Compelling Growth Prospects For H2 2022 And Beyond
Aug 08Do Amphastar Pharmaceuticals' (NASDAQ:AMPH) Earnings Warrant Your Attention?
Jul 24Amphastar generic vasopressin for increasing blood pressure gets FDA approval
Jul 19We Think Amphastar Pharmaceuticals (NASDAQ:AMPH) Can Manage Its Debt With Ease
Jun 10Amphastar Pharmaceuticals: Stock With An Attractive 6 To 1 Risk-Reward Ratio
May 13I Ran A Stock Scan For Earnings Growth And Amphastar Pharmaceuticals (NASDAQ:AMPH) Passed With Ease
Apr 23These 4 Measures Indicate That Amphastar Pharmaceuticals (NASDAQ:AMPH) Is Using Debt Safely
Feb 13Amphastar Pharma: A Well-Run, Diversified Mid Cap
Jan 26Should You Be Adding Amphastar Pharmaceuticals (NASDAQ:AMPH) To Your Watchlist Today?
Jan 08CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | US$8m | US$898k | US$138m |
| Sep 30 2023 | n/a | n/a | US$135m |
| Jun 30 2023 | n/a | n/a | US$102m |
| Mar 31 2023 | n/a | n/a | US$93m |
| Dec 31 2022 | US$7m | US$1m | US$91m |
| Sep 30 2022 | n/a | n/a | US$77m |
| Jun 30 2022 | n/a | n/a | US$91m |
| Mar 31 2022 | n/a | n/a | US$81m |
| Dec 31 2021 | US$7m | US$898k | US$62m |
| Sep 30 2021 | n/a | n/a | US$36m |
| Jun 30 2021 | n/a | n/a | US$10m |
| Mar 31 2021 | n/a | n/a | US$2m |
| Dec 31 2020 | US$6m | US$898k | US$1m |
| Sep 30 2020 | n/a | n/a | US$7m |
| Jun 30 2020 | n/a | n/a | US$4m |
| Mar 31 2020 | n/a | n/a | US$52m |
| Dec 31 2019 | US$6m | US$898k | US$49m |
| Sep 30 2019 | n/a | n/a | US$52m |
| Jun 30 2019 | n/a | n/a | US$53m |
| Mar 31 2019 | n/a | n/a | US$2m |
| Dec 31 2018 | US$6m | US$1m | -US$6m |
| Sep 30 2018 | n/a | n/a | -US$7m |
| Jun 30 2018 | n/a | n/a | -US$9m |
| Mar 31 2018 | n/a | n/a | -US$4m |
| Dec 31 2017 | US$6m | US$880k | US$4m |
Compensation vs Market: Jack's total compensation ($USD7.72M) is above average for companies of similar size in the US market ($USD5.55M).
Compensation vs Earnings: Jack's compensation has been consistent with company performance over the past year.
CEO
Jack Zhang (76 yo)
28.3yrs
Tenure
US$7,722,768
Compensation
Dr. Yongfeng Zhang, also known as Jack, Ph D., has been President at Amphastar Pharmaceuticals, Inc. since April 10, 2020. He co-founded Amphastar Pharmaceuticals in 1996 and has been its Chief Executive O...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board | 28.3yrs | US$3.77m | 2.35% $ 46.9m | |
| Co-founder | 28.3yrs | US$7.72m | 4.58% $ 91.6m | |
| CFO, Executive VP of Finance | 10yrs | US$2.89m | 0.081% $ 1.6m | |
| Executive VP of Sales | 10.8yrs | US$1.78m | 0.093% $ 1.9m | |
| Senior Executive Vice President of Production | 8.8yrs | US$2.03m | 0.38% $ 7.6m | |
| Vice President of Human Resources & Corporate Communication | 1.7yrs | no data | no data | |
| Senior VP of Regulatory Affairs & Clinical Operations | no data | no data | no data |
10.4yrs
Average Tenure
64yo
Average Age
Experienced Management: AMPH's management team is seasoned and experienced (10.4 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board | 28.3yrs | US$3.77m | 2.35% $ 46.9m | |
| Co-founder | 28.3yrs | US$7.72m | 4.58% $ 91.6m | |
| CFO, Executive VP of Finance | 1.7yrs | US$2.89m | 0.081% $ 1.6m | |
| Executive VP of Sales | 1.7yrs | US$1.78m | 0.093% $ 1.9m | |
| Lead Independent Director | 22.2yrs | US$362.00k | 0.058% $ 1.2m | |
| Independent Director | 2.8yrs | US$330.00k | 0% $ 0 | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 4.8yrs | US$314.70k | 0.026% $ 525.4k |
4.8yrs
Average Tenure
64.5yo
Average Age
Experienced Board: AMPH's board of directors are considered experienced (4.8 years average tenure).